Verdiva Bio Revenue and Competitors
Estimated Revenue & Valuation
- Verdiva Bio's estimated annual revenue is currently $7.1M per year.
- Verdiva Bio's estimated revenue per employee is $155,000
- Verdiva Bio's total funding is $411M.
Employee Data
- Verdiva Bio has 46 Employees.
Verdiva Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific Officer & Co Founder | Reveal Email/Phone |
3 | Executive Assistant to the CMO Office | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | Chief Business Officer | Reveal Email/Phone |
9 | VP, Head Commercial Strategy | Reveal Email/Phone |
10 | VP Manufacturing | Reveal Email/Phone |
Verdiva Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Verdiva Bio?
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options. \n\nOur most advanced therapy is VRB-101, an oral GLP-1 peptide in clinical development that has demonstrated best-in-class efficacy potential in a phase 1 study in Australia, which also confirmed the viability of once-weekly dosing. \n\nWe are also developing a portfolio of amylin molecules, including oral and subcutaneous agonists, and other undisclosed programs that offer the potential for enhanced efficacy, improved tolerability, and healthier weight loss. \n\nThe Verdiva team will harness the emerging science in gut-brain biology and leverage their history of successful drug development to advance novel therapeutic options aiming to transform the lives of millions living with obesity worldwide.\nFor more information, please visit www.verdivabio.com.
keywords:N/A
$411M
Total Funding
46
Number of Employees
$7.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.4M | 46 | -16% | N/A |
#2 | $5.9M | 46 | -13% | N/A |
#3 | $8.1M | 46 | 0% | N/A |
#4 | $4.8M | 46 | -28% | N/A |
#5 | $5.2M | 46 | 18% | $221.1M |